ZOMETA INJECTION 4mg/5ml Vial
Generic Name: Zoledronic Acid
Zometa Injection (Zoledronic Acid) is a prescription medication used primarily to treat high levels of calcium in the blood caused by cancer. It is also effective in the management of bone complications in patients with certain types of cancer, such as multiple myeloma and bone metastases from solid tumors.
Zometa is indicated for:
The recommended dosage for Zometa Injection is typically administered as an intravenous infusion. Dosage may vary based on the specific condition being treated, the patient's kidney function, and other individual factors. It is crucial to follow the healthcare provider's instructions regarding dosage and administration.
Zoledronic Acid, the active ingredient in Zometa, is a bisphosphonate that inhibits osteoclast-mediated bone resorption. This action helps to maintain bone density and reduce the risk of fractures in patients with compromised bone health due to cancer or other conditions.
Common side effects of Zometa may include:
Serious side effects can occur and should be reported to a healthcare provider immediately, including signs of allergic reactions, kidney problems, or jaw osteonecrosis.
Before using Zometa, inform your doctor about any existing medical conditions, particularly kidney issues, and any medications you are currently taking. Regular monitoring of kidney function is recommended during treatment.
Zometa Injection should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F) and protected from light. Do not freeze. Keep out of reach of children and dispose of any unused medication properly.
Always consult with a healthcare professional for personalized medical advice, potential drug interactions, and to discuss any concerns regarding the use of Zometa Injection.